Nowadays, people live a busy life. Even have entered middle age, people still want to keep in the best condition and face various challenges continuously, and not to be impacted by Presbyopia. Therefore, the demand for multifocal contact lenses is gradually increasing.
Though fitting multifocal contact lenses may be relatively complicated, but if fitting is successful, this can enhance their trust & confidence to you. In addition, when patients’ Presbyopia progresses, they will return. So, what you need is a multifocal contact lens that is easy and flexible to use. This can help you increase fitting success rate while building long term relationships with your patients.
The newly designed clariti® 1 day Multifocal features CooperVision Binocular Progressive System™ and 3 ADD power design, helps you to fit for your Presbyope customers easily, making “Success is Simple” for your fittings1.
Features & Benefits
- Features CooperVision Binocular Progressive System™ with 3 ADD powers and easy-to-use fitting guide, providing high level visual acuity even there is change in prescription or visual needs1, helping you to fit more easily for different levels of Presbyopes and improve efficiency.
- Provides widest power range so you can fit for more patients*2
- Features the new Optimized Comfort Edge™ design, providing a more comfortable experience†3
- 3 times oxygen transmissibility‡, providing 100% required oxygen for eyes§4
- Wetloc™ Technology features naturally wettable material, keeping the lens moist throughout the day supporting comfort during the day1
- An excellent value for money choice for entry level silicon hydrogel multifocal contact lens
- Supports sustainability and is plastic neutral ¶5
Success is Simple : Binocular Progressive System™
|
|
Success is Simple : Easy & Efficient Fitting
Easy-to-use fitting guide: the dominant eye always wears LOW ADD, and the non-dominant eye wears low, medium or high ADD, depending on the prescription.
- Offers an innovative flexible multifocal lens design, adjustment is easy even there is change in Presbyopia prescriptions1
- Clinically proven, 100% fitting success rate8 (with no more than 2 pairs of trial lenses)
- Utilize OptiExpert™, a fitting app that can help you select the most appropriate CooperVision® contact lens:
Success is Simple : Widest Power Range
Provide the widest power range*2 in the daily multifocal contact lens market:
Improved Comfort : Optimized Comfort Edge™ The Upgraded Lens Edge Design
|
|
Naturally hydrated without additives : Wetloc Technology™
| Wetloc Technology™ contains natural water-loving hydrophilic properties 1 without additives or wetting agents in the lens material or lens surface, keeping your eyes naturally wettable all day. |
Begin the breathable & healthy wearing experience for your patients : Highly breathable silicon hydrogel material
| Highly breathable silicon hydrogel material allows up to 3 times oxygen transmission‡, providing 100% required oxygen for eyes§4, offering a healthy contact lens choice|10 |
Sustainable and protect the Earth together
| clariti ® 1 day is the first CooperVision brand that supports plastic neutrality, contributing to reduce plastic waste in oceans and protect the Earth¶ 5. |
Product Details
Product Details
* As of Jan 2025
† Of those who stated a preference, n=11/12 either strongly or slightly preferred the new edge design upon dispense
‡ Based on manufacturers published data. clariti 1 day has Dk/t of 86. Compared to Proclear 1 day (Dk/t 28), 1-day Acuvue Moist (Dk/t 25.5), Dailies Aquacomfort Plus (Dk/t 26) and Biotrue ONEday (Dk/t 42).
§ During daily wear
| With higher oxygen delivery than hydrogel materials, SiHy materials minimize or eliminate hypoxia-related complications during daily wear.
¶'- clariti® 1 day is defined as orders and includes clariti® 1 day sphere, clariti® 1 day toric, and clariti® 1 day multifocal product sold & distributed by CooperVision Globally.
- Plastic neutrality is established by purchasing credits from Plastic Bank. A credit represents the collection and conversion of one kilogram of plastic that may reach or be destined for waterways. CooperVision purchases credits equal to the weight of plastic in clariti® 1 day orders in a specified time period. clariti® 1 day plastic is determined by the weight of plastic in the blister, the lens, and the secondary package, including laminates, adhesives, and auxiliary inputs (e.g. ink)
- Based on top 4 global contact lens manufacturers.
** Refers to Select 1 day
†† Warning: UV-absorbing contact lenses are not substitutes for protective UV-absorbing eyewear, such as UV-absorbing goggles or sunglasses, because they do not completely cover the eye and surrounding area. Patients should continue to use UV-absorbing eyewear as directed.
References:
CVI data on file, 2024.
CVI data on file 2025. Based on prescription option combinations (sph and add) available across all daily disposable multifocal soft contact lenses from CVI, JJV, B+L and Alcon in Hong Kong as of 2025.
CVI data on file, 2015. Non-dispensing, double-masked, randomized, contralateral study in US. N=20
Brennan NA. Beyond Flux: Total Corneal Oxygen Consumption as an Index of Corneal Oxygenation During Contact Lens Wear. Optom Vis Sci. 2005;82(6):467-472
CVI data on file, 2022
CVI data on file, 2024. CVI data on file, 2020. Prospective, double-masked, bilateral, 1-week dispensing study with MyDay daily disposable multifocal; n=104 habitual MFCL wearers. CVI data on file 2021. Prospective, double-masked, bilateral, one-week dispensing study with clariti® 1 day multifocal 3 add; with ratings from 85 to 89 out of 100; n=90 habitual MFCL wearers.
CVI data on file.
CVI data on file, 2024. CVI data on file, 2021. Prospective, double-masked, bilateral, one-week dispensing study with clariti® 1 day multifocal 3 add; n=90 habitual MFCL wearers
CVI data on file 2021. Prospective, double-masked, bilateral, one-week dispensing study with clariti® 1 day multifocal 3 add; with a rating of 93 out of 100; n=90 habitual MFCL wearers
CVI data on file, 2020; Sulley A, Dumbleton K. Silicone hydrogel daily disposable benefits: The evidence. CLAE;43(3):298-307